Pre-clinical CRO ZHSK Lab Nets Over CNY 100 Mn in Series B

ZSHK, a pre-clinical Contract Research Organization (“Preclinical CRO”), raised funds from AZ-CICC and its existing investor Jishi Capital to enhance international deployment and key resources construction ZSHK Laboratories Limited (“ZSHK LAB”) (Chinese: 滬港中科), a pre-clinical CRO, an

Read more: https://equalocean.com/news/2022120119256

迴響已關閉。

在 WordPress.com 建立網站或網誌

向上 ↑

%d 位部落客按了讚: